(2-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid, 95.0%, 250mg

(3-((Phenylamino)methyl)phenyl)boronic acid, 98%, 1g

endo-3-Bromo-D-camphor, 25g

(2-Methoxy-5-methylpyridin-3-yl)boronic acid, 95.0%, 1g

tert-Butyl (3-(hydroxymethyl)phenyl)carbamate, 97.0%, 25g

2-Ethyl-2-methylbutanoic acid, 95.0%, 100mg

1-(4-bromo-3-chlorophenyl)-2,2,2-trifluoroethanone, 1g

D(+)-Maltose monohydrate, min. 92%, for biochemistry, 500 g, plastic packaging.

Ethyl 2,5-dichlorobenzoate, 95.0%, 25g

3-Aminopyrazine-2-carbonitrile, 95.0%, 1g

5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone, 95.0%, 250mg

2-(4-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine>98.0%(GC)(N)1g

6-Chloro-1H-benzo[d]imidazol-2-amine hydrobromide, 97%, 1g